Article
Evolution of drug-resistant mutations in HBV genomes in patients with treatment failure during the past seven years (2010-2016).
Virus genes - 1 Feb 2018
Zhang Hong-Yu, Liu Long-Gen, Ye Chun-Yan, Chen Chun-Hua, Hang Shuang-Xiong, Zhu Zhen, Shen Hong-Yu, Huang Ze-Yu, Chen Wen-Yi, Xue Yuan
Abstract excerpt
The objective of this study was to analyze the prevalence of drug-resistant HBV mutants in patients with treatment failure during the past seven years (2010-2016). 4055 HBV-infected patients who underwent HBV polymerase gene mutation test from 2010 to 2016 were enrolled. The nucleos(t)ide analogues (NAs) resistance mutation positions, including rtL180, rtA181, rtT184, rtS202, rtM204, rtI233, rtN236, rtI169,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
